Skip to main content
. 2021 Nov 16;13:8629–8646. doi: 10.2147/CMAR.S336672

Table 6.

Patients’ Information from Qilu Hospital

Clinical Character Resistant (%) Sensitive (%) P-value
Age at diagnosis ≥55 10 (16.1) 13 (21.0) 0.33
<55 22 (35.5) 17 (27.4)
Stage I 4 (6.5) 2 (3.2) 0.66
II 2 (3.2) 3 (4.8)
III 26 (41.9) 25 (40.3)
Histology High-grade serous 30 (48.4) 29 (46.8) >0.99
Low-grade serous 2 (3.2) 1 (1.6)
Survival information Alive 8 (12.9) 20 (32.3) 0.001
Death 24 (38.7) 10 (16.1)